In vitro characterization and pre-clinical pharmacokinetics of CP-870,893, a human anti-CD40 agonist antibody.

被引：0
|
作者：
Bedian, V. [1 ]
Donovan, C. [1 ]
Gardner, J. [1 ]
Natoli, E. [1 ]
Paradis, T. [1 ]
Alpert, R. [1 ]
Wang, H. [1 ]
Shepard, R. [1 ]
Wentland, J. [1 ]
Gladue, R. [1 ]
机构：
[1] Pfizer Global Res & Dev, Groton, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109S / 109S
页数：1
相关论文
共 48 条
  • [1] Surface expression of CD40 on human melanoma and the direct in vitro growth effects of an anti-CD40 agonist antibody, CP-870,893
    Kalbasi, A.
    Chmielowski, B.
    Ribas, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 223 - 224
  • [2] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
    Vonderheide, R. H.
    Flaherty, K. T.
    Khalil, M.
    Stumacher, M. S.
    Bajor, D. L.
    Gallagher, M.
    Sullivan, P.
    Mahaney, J. J.
    O'Dwyer, P. J.
    Huhn, R. D.
    Antonia, S. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 101S - 101S
  • [3] CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893
    Kalbasi, Anusha
    Fonsatti, Ester
    Natali, Pier Giorgio
    Altomonte, Maresa
    Bertocci, Erica
    Cutaia, Ornella
    Calabro, Luana
    Chiou, Michael
    Tap, William
    Chmielowski, Bartosz
    Maio, Michele
    Ribas, Antoni
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 810 - 816
  • [4] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
    Vonderheide, Robert H.
    Flaherty, Keith T.
    Khalil, Magi
    Stumacher, Molly S.
    Bajor, David L.
    Hutnick, Natalie A.
    Sullivan, Patricia
    Mahany, J. Joseph
    Gallagher, Maryann
    Kramer, Amy
    Green, Stephanie J.
    O'Dwyer, Peter J.
    Running, Kelli L.
    Huhn, Richard D.
    Antonia, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 876 - 883
  • [5] A phase I study of CD40 agonist monoclonal antibody (CP-870,893) with gemcitabine in pancreatic cancer.
    Beatty, G. L.
    Chiorean, E. G.
    Torigian, D. A.
    Teitelbaum, U. R.
    Sun, W.
    Fly, K. D.
    Huhn, R. D.
    Vonderheide, R. H.
    O'Dwyer, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
    Erica L Carpenter
    Rosemarie Mick
    Jens Rüter
    Robert H Vonderheide
    Journal of Translational Medicine, 7
  • [7] Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
    Carpenter, Erica L.
    Mick, Rosemarie
    Rueter, Jens
    Vonderheide, Robert H.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7 : 93
  • [8] Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
    Vonderheide, Robert H.
    Burg, Jennifer M.
    Mick, Rosemarie
    Trosko, Jennifer A.
    Li, Dongguang
    Shaik, M. Naveed
    Tolcher, Anthony W.
    Hamid, Omid
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [9] Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma
    Bajor, David L.
    Mick, Rosemarie
    Riese, Matthew J.
    Richman, Lee P.
    Xu, Xiaowei
    Torigian, Drew A.
    Stelekati, Erietta
    Sweeney, Martha
    Sullivan, Brendan
    Schuchter, Lynn M.
    Amaravadi, Ravi
    Wherry, E. John
    Vonderheide, Robert H.
    CANCER RESEARCH, 2015, 75
  • [10] A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
    Beatty, Gregory L.
    Torigian, Drew A.
    Chiorean, E. Gabriela
    Saboury, Babak
    Brothers, Alex
    Alavi, Abass
    Troxel, Andrea B.
    Sun, Weijing
    Teitelbaum, Ursina R.
    Vonderheide, Robert H.
    O'Dwyer, Peter J.
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6286 - 6295
12345